Not applicableStudy completedNCT03276286What this trial is testingNativis Voyager for Newly Diagnosed GBMWho this might be right forGlioblastoma Multiforme Nativis, Inc. 37
Testing effectiveness (Phase 2)Study completedNCT01285414What this trial is testingVerubulin, Radiation Therapy, and Temozolomide to Treat Patients With Newly Diagnosed Glioblastoma MultiformeWho this might be right forGlioblastoma Multiforme Myrexis Inc. 5
Testing effectiveness (Phase 2)Study completedNCT00005952What this trial is testingTemozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid TumorsWho this might be right forBrain and Central Nervous System TumorsChildhood Germ Cell TumorHead and Neck Cancer+5 more Duke University 30
Early research (Phase 1)Study completedNCT00650923What this trial is testingAflibercept, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Multiforme, Gliosarcoma, or Other Malignant GliomaWho this might be right forAdult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Giant Cell Glioblastoma+4 more National Cancer Institute (NCI) 61
Early research (Phase 1)Active Not RecruitingNCT06973096What this trial is testingCART-EGFR-IL13Ra2 in Newly Diagnosed GBM Following Initial RadiotherapyWho this might be right forGlioblastoma University of Pennsylvania 9
Large-scale testing (Phase 3)Ended earlyNCT00615186What this trial is testingGlioblastoma Multiforme (GBM) Locoregional Agent Survival Study - Anti-tenascin Radiolabeled Antibody TherapyWho this might be right forGlioblastoma Multiforme Bradmer Pharmaceuticals Inc. 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT04677049What this trial is testingStudy of Niacin in GlioblastomaWho this might be right forGlioblastoma IDH (Isocitrate Dehydrogenase) Wildtype AHS Cancer Control Alberta 59
Large-scale testing (Phase 3)Active Not RecruitingNCT05095376What this trial is testingTesting the Addition of the Chemotherapy Drug Lomustine (Gleostine) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated GlioblastomaWho this might be right forGlioblastomaGliosarcoma NRG Oncology 265
Testing effectiveness (Phase 2)Study completedNCT00002752What this trial is testingRadiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain CancersWho this might be right forBrain and Central Nervous System TumorsMetastatic Cancer Duke University
Early research (Phase 1)Study completedNCT03726515What this trial is testingCART-EGFRvIII + Pembrolizumab in GBMWho this might be right forGlioblastoma University of Pennsylvania 7
Testing effectiveness (Phase 2)Study completedNCT00058097What this trial is testingTipifarnib and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeWho this might be right forAdult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma National Cancer Institute (NCI) 54
Early research (Phase 1)Ended earlyNCT02664363What this trial is testingEGFRvIII CAR T Cells for Newly-Diagnosed WHO Grade IV Malignant GliomaWho this might be right forGlioblastomaGliosarcoma Daniel Landi 3
Testing effectiveness (Phase 2)Study completedNCT04119674What this trial is testingPilot Study of Anlotinib With STUPP Regimen for Patients With Newly Diagnosed GlioblastomaWho this might be right forGlioblastoma Zhejiang Cancer Hospital 33
Testing effectiveness (Phase 2)UnknownNCT03400917What this trial is testingAutologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens for Treatment of Newly Diagnosed GlioblastomaWho this might be right forNewly Diagnosed Glioblastoma Aivita Biomedical, Inc. 55
Testing effectiveness (Phase 2)Study completedNCT04817254What this trial is testingAssociation of Peripheral Blood Immunologic Response to Therapeutic Response to Adjuvant Treatment With Immune Checkpoint Inhibition (ICI) in Patients With Newly Diagnosed Glioblastoma or GliosarcomaWho this might be right forGlioblastomaGliosarcomaMalignant Glioma National Cancer Institute (NCI) 47
Early research (Phase 1)Active Not RecruitingNCT04015700What this trial is testingNeoantigen-based Personalized DNA Vaccine in Patients With Newly Diagnosed, Unmethylated GlioblastomaWho this might be right forGlioblastoma Washington University School of Medicine 9
Testing effectiveness (Phase 2)Ended earlyNCT01822275What this trial is testingPhase II Trial of Low-Dose Whole Brain Radiotherapy With Concurrent Temozolomide and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma MultiformeWho this might be right forHistologically Proven Diagnosis of Glioblastoma or Gliosarcoma (WHO Grade IV) University of Maryland, Baltimore 24
Early research (Phase 1)Looking for participantsNCT07141732What this trial is testingCombined Treatment of Patients With Newly Diagnosed Glioblastoma Using the Xoft® Axxent® Electronic Brachytherapy (eBx®) System for Intraoperative Balloon Electronic BrachytherapyWho this might be right forGlioblastoma Joint Stock Company European Medical Centre 15
Not applicableUnknownNCT02047058What this trial is testingTreatment Response and Prognosis in Glioma Patients: Q Cell and Its Biological CharacteristicsWho this might be right forGlioblastomaMalignant Glioma Nanfang Hospital, Southern Medical University 240
Testing effectiveness (Phase 2)Study completedNCT03782415What this trial is testingStudy to Evaluate Ibudilast and TMZ Combo Treatment in Newly Diagnosed and Recurrent GlioblastomaWho this might be right forGlioblastomaRecurrent GlioblastomaGBM+1 more MediciNova 64